AstraZeneca reportedly in talks to combine with U.S. Bristol Myers Squibb in a deal that would create one of the world’s biggest pharmaceutical groups, valued at nearly $400 billion .

JUST IN - AstraZeneca reportedly in talks to combine with U.S. Bristol Myers Squibb in a deal that would create one of the world’s biggest pharmaceutical groups, valued at nearly $400 billion . Read here: disclose.tv › f2mt86zoju (disclose.tv › f2mt86zoju) @disclosetv (t.me › disclosetv)